Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Single oral dose of maraviroc does not prevent ex-vivo HIV infection of rectal mucosa in HIV-1 negative human volunteers.
The lipid-lowering effect of tenofovir/emtricitabine: a randomized, crossover, double-blind, placebo-controlled trial.
Clinical value of ultradeep HIV-1 genotyping and tropism testing in late presenters with advanced disease.
HIV resistance testing and detected drug resistance in Europe.
Transmission of HIV drug resistance: lessons from sensitive screening assays.
Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences.
Monotherapy with boosted PIs as an ART simplification strategy in clinical practice.
2015 Update of the Drug Resistance Mutations in HIV-1.
Randomized, crossover, double-blind, placebo-controlled trial to assess the lipid lowering effect of co-formulated TDF/FTC.
Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic.